VERU INC. Inventory, Gross
VERU INC. (VERU) had Inventory, Gross of $5.73 million as of 2024-09-30, per its 10-K filed 2024-12-16.
Financial Statements › Notes › Inventory, Gross
us-gaap:InventoryGross · last filed 2024-12-16
- 2024-09-30: Inventory, Gross $5.73M.
- 2024-06-30: Inventory, Gross $6.39M.
- 2024-03-31: Inventory, Gross $5.75M.
- 2023-12-31: Inventory, Gross $7.07M.
| Period end | Inventory, Gross |
|---|---|
| 2024-09-30 | $5.73M 10-K · filed 2024-12-16 |
| 2024-06-30 | $6.39M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $5.75M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $7.07M 10-Q · filed 2024-04-01 |
| 2023-09-30 | $6.88M 10-K · filed 2024-12-16 |
| 2023-06-30 | $6.70M 10-Q/A · filed 2023-11-15 |
| 2023-03-31 | $7.87M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $8.75M 10-Q · filed 2023-02-09 |
| 2022-09-30 | $8.63M 10-K/A · filed 2024-04-01 |
| 2021-09-30 | $6.03M 10-K · filed 2022-12-05 |
| 2017-09-30 | $3.05M 10-K · filed 2018-01-02 |
| 2016-09-30 | $2.51M 10-K · filed 2018-01-02 |
| 2016-06-30 | $2.37M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $2.23M 10-Q · filed 2016-04-28 |
| 2015-12-31 | $1.59M 10-Q · filed 2016-02-02 |
| 2015-09-30 | $1.78M 10-K · filed 2016-12-12 |
| 2015-06-30 | $2.64M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $2.85M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $3.52M 10-Q · filed 2015-02-03 |
| 2014-09-30 | $3.04M 10-K · filed 2015-12-02 |
| 2014-06-30 | $3.05M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $4.15M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $2.56M 10-Q · filed 2014-02-03 |
| 2013-09-30 | $2.50M 10-K · filed 2014-12-02 |
| 2013-06-30 | $2.85M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $2.51M 10-Q · filed 2013-05-02 |
| 2012-12-31 | $1.85M 10-Q · filed 2013-01-30 |
| 2012-09-30 | $1.51M 10-K · filed 2013-12-03 |
| 2012-06-30 | $1.43M 10-Q · filed 2012-07-31 |
| 2011-09-30 | $2.10M 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |